Biogen Inc. (BIIB)

Last Closing Price: 192.03 (2026-02-20)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Biogen Inc. (BIIB) had Net Income of $1.29B for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$9.89B
Net Income
$1.29B
$2.40B
$7.49B
$8.03B
$1.86B
$-305.60M
$1.56B
$1.56B
$1.29B
$1.29B
$1.29B
$1.29B
$1.86B
$2.94B
146.50M
147.10M
$8.83
$8.79
Balance Sheet Financials
$8.97B
$3.06B
$20.47B
$29.44B
$3.35B
$6.29B
$7.83B
$11.18B
$18.26B
$2.59B
$18.26B
146.70M
Cash Flow Statement Financials
$2.20B
$-1.37B
$-301.90M
$2.38B
$3.01B
$633.50M
$290.80M
--
--
Fundamental Metrics & Ratios
2.68
--
--
0.26
0.34
75.69%
18.83%
18.83%
29.68%
15.74%
13.07%
$2.05B
--
--
--
0.34
1.11
7.37
49.54
7.08%
49.97%
4.39%
5.27%
$124.45
$13.94
$14.99